Wordt geladen...
Development of therapeutic agents for elderly patients with acute myelogenous leukemia
Acute myelogenous leukemia (AML) is a disease more common in the elderly than the young. It is increasingly recognized that conventional cytotoxic chemotherapies used in children and young adults may not be appropriate in older adults because of diverse host- and disease-biology factors. This review...
Bewaard in:
| Gepubliceerd in: | Curr Opin Investig Drugs |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699173/ https://ncbi.nlm.nih.gov/pubmed/20496262 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|